...Private Equity Funds; InnoBio Fund; Edmond de Rothschild Investment Partners; LBP S.A.; BrevImmo; Beaufagne S.A.; Whitehall...

...an oral formulation of an over the counter (OTC) product to be marketed by AHP's Whitehall-Robins...

...AHP failed to meet its obligations under the 1997 agreement. Carol Dornbush, spokesperson for AHP's Whitehall-Robbins...

...as a food ingredient to the U.S. processed food industry. American Home Products Corp. 's Whitehall-Robins...

...AHP's Whitehall-Robins Healthcare division (Madison, N.J.) received an exclusive license to sell AMBI's Cardia salt alternative...

...Whitehall will use FUSE's Ceform EA drug delivery technology to produce an undisclosed OTC product. Whitehall...
...will receive technology access fees, milestone payments and royalties. Fuisz Technologies Ltd. (FUSE), Chantilly, Va. Whitehall-Robins...

...product launch by year end. FUSE also said it renegotiated agreements with Boots, SmithKline and Whitehall-Robins...
...Boots Co., Nottingham, U.K. McNeil Consumer Products Co., Fort Washington, Penn. SmithKline Beecham, Philadelphia, Penn. Whitehall-Robins...

...use PPRT's PharmaPrint Process technology to develop bioactively standardized herbal products for sale by AHP's Whitehall-Robins...

...Hoechst Celanese, ConAgra, The Boots Co., J&J's McNeil Consumer Products division and American Home Products' Whitehall...
...Hoechst Celanese, ConAgra, The Boots Co., J&J's McNeil Consumer Products division and American Home Products' Whitehall...

...FUSE received a license fee milestone payment from AHP's Whitehall division under their collaboration to develop...
...collaboration to develop rapid dissolve and chewable tablet formulations of an over-the-counter product marketed by Whitehall...